Selective serotonin reuptake inhibitor use and risk of gestational hypertension.
about
The risks of selective serotonin reuptake inhibitor use in infertile women: a review of the impact on fertility, pregnancy, neonatal health and beyondParoxetine-The Antidepressant from Hell? Probably Not, But Caution RequiredDelivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data.Developmental origins of health and disease: environmental exposures.Antidepressant use and risk for preeclampsia.Treatment of nonpsychotic major depression during pregnancy: patient safety and challengesThe effect of antenatal depression and selective serotonin reuptake inhibitor treatment on nerve growth factor signaling in human placenta.Psychosocial interventions for perinatal common mental disorders delivered by providers who are not mental health specialists in low- and middle-income countries: a systematic review and meta-analysisAntidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction.Association between pre-pregnancy depression/anxiety symptoms and hypertensive disorders of pregnancyDepression in pregnancy is associated with preexisting but not pregnancy-induced hypertension.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?Effects of Fluoxetine on Human Embryo Development.Can Antidepressant Drug Impact on Blood Pressure Level in Patients with Psychiatric Disorder and Hypertension? A Randomized Trial.Antidepressant use during pregnancy and the risk of pregnancy-induced hypertension.Antidepressant use and gestational hypertension: does evidence support causality?Antidepressant use and gestational hypertension: does evidence support causality? Reply letter.The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspringThe use of central nervous system active drugs during pregnancy.Risk factors and prediction of preeclampsia.Use of psychotropic medication during pregnancy and the postpartum period.The risks associated with prenatal antidepressant exposure: time for a precision medicine approach.Risk of gestational hypertension and preeclampsia in women who discontinued or continued antidepressant medication use during pregnancy.Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes.Prenatal exposure to antidepressants and risk of epilepsy in childhood.Parsing risk for the use of selective serotonin reuptake inhibitors in pregnancy.Antidepressant medication use, depression, and the risk of preeclampsia.Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population-based study in six European regions.Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study.Bias from restricting to live births when estimating effects of prescription drug use on pregnancy complications: A simulation.TCTP as a therapeutic target in melanoma treatment.Antidepressant use during pregnancy and the risk of developing gestational hypertension: a retrospective cohort study.
P2860
Q27010327-115107F0-B490-4D37-A735-FE25F7ACD985Q28069392-208BC532-4739-478A-BC9F-1AFC74923F71Q33521786-8603FA28-D890-468C-9826-369FB4539241Q33822673-9884729A-C7AD-420A-A932-A898A0177D9FQ34158083-1AD74AD7-BD1C-4E66-B70B-720A5EC9AC52Q34237681-3998A279-CBC0-48FD-B278-4580E84DCE60Q35000963-4986B8C9-37E8-4FB2-B599-4E955C6C6886Q35034078-FAF8E835-FB5B-45C4-9AA3-2DEFA9DE990EQ35506589-2B10B749-736B-4CA1-A866-2B8EB91219F2Q35641596-D1A341C4-4E33-4231-924F-C5B71EE0E300Q35661309-A210D8EB-1D31-46F3-B10A-3D9F85AD4E69Q35862776-DAEEF0AC-5BC6-4158-9A7A-D2F21312061CQ35963098-4B3A39E5-B5B4-4692-A920-36CE1EB1B839Q36068009-98550A40-B260-4C30-99D6-B5E8FCE187BDQ36584667-C3A0DB1F-ABEE-47D0-875B-DF0054568988Q36779157-2276CB49-F306-4408-A1D5-0B6442EAFED0Q36793021-FF6B6014-918D-4C25-874D-8493985D13DFQ36793025-F3E491F5-0415-4478-953E-94E77C4C85D9Q36860205-53A715D4-8562-4AF7-98BA-54827BC5229DQ37280003-74270614-020C-47E0-9A7B-61F9F76C4A8AQ37725865-4605EEAA-4826-42F5-BFAC-6D671B4B8421Q38155675-03F2D830-5FA1-428D-945B-3011C0846A26Q38722632-2399786E-1688-41DE-A6C1-7B470749A416Q39456421-EF13C41A-CBC5-4A1A-8FD1-C6BAFD7B352FQ40043224-358D4CB4-8600-4786-8F14-F623E96F47C2Q40498883-2BE8590D-F90C-4829-95F3-C7CAC306DB2CQ42733992-BF0A0C0E-2F96-4A81-8E0A-9CB22D5077BEQ46220428-9C7FDE32-A380-4D37-9677-2BF46FDD3044Q46625070-F9F86CEB-8941-4917-A5E1-202C04D4EBC7Q47136710-A6EF2B70-34F0-4849-96CB-F38747E812FBQ47562172-405E8DF0-4AAF-43F9-9787-B70FCA01F13EQ48018765-AAF6214B-101A-46B8-BA19-F2CA04FB7642Q55379353-6DAA008E-B940-4907-B544-340F08B5C8FA
P2860
Selective serotonin reuptake inhibitor use and risk of gestational hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Selective serotonin reuptake inhibitor use and risk of gestational hypertension.
@en
Selective serotonin reuptake inhibitor use and risk of gestational hypertension.
@nl
type
label
Selective serotonin reuptake inhibitor use and risk of gestational hypertension.
@en
Selective serotonin reuptake inhibitor use and risk of gestational hypertension.
@nl
prefLabel
Selective serotonin reuptake inhibitor use and risk of gestational hypertension.
@en
Selective serotonin reuptake inhibitor use and risk of gestational hypertension.
@nl
P2093
P2860
P1476
Selective serotonin reuptake inhibitor use and risk of gestational hypertension.
@en
P2093
Allen A Mitchell
Carol Louik
Christina D Chambers
Martha M Werler
Sengwee Toh
Sonia Hernández-Díaz
P2860
P304
P356
10.1176/APPI.AJP.2008.08060817
P407
P577
2009-01-02T00:00:00Z